Cite
HARVARD Citation
Laise, P. et al. (2022). A Patient‐to‐Model‐to‐Patient (PMP) Cancer Drug Discovery Protocol for Identifying and Validating Therapeutic Agents Targeting Tumor Regulatory Architecture. Current protocols. 2 (9), p. n/a. [Online].